Human papillomavirus infection is a causative factor for the majority of anogenital cancers. As a consequence of the expression of the HPV E6 and E7 genes, normally quiescent epithelial cells proliferate. The ability to cease proliferating in response to exogenous DNA damaging agents, or in response to the genetic alterations that occur during senescence or crisis in culture, is lost in the HPV containing cells. This likely results in the appearance of preneoplastic lesions or squamous intraepithelial lesions (SIL) in vivo, or immortalized cells in culture, though SIL and immortalized cell lines may not be entirely analogous. We propose that the E7 gene is responsible for inducing proliferation by freeing E2F from Rb or p107, and that the induction of proliferation is independent of the state of p53 since E7 expression alone induces proliferation and high levels of p53, or E7 together with E6 induces proliferation despite the low levels of p53 resulting from the ability of E6 to target p53 for ubiquitin-mediated degradation. The ability to proliferate in the presence of high levels of p53 is an interesting paradox and specific aim one asks whether the p53 that is post- translationally stabilized by E7 expression is structurally and functionally equivalent to the growth repressive form of p53. The ability of p53 to transactivate or repress promoters, bind to DNA or TBP, and its conformation and phosphorylation state will be examined. Both E7 and E6 are able to abrogate the normal G1 checkpoint that prevents the transit of DNA damaged cells into S phase.
Specific aim 2 will use mutants of E7 to determine whether the ability of E7 to arrest in G1 is dependent on the ability to bind Rb/P107 rather than the ability to stimulate proliferation or p53 stabilization. Our preliminary data suggest that p53, that is activated in response to DNA damage, inhibits the phosphorylation of Rb which is required for transit into S; E6 disrupts the pathway by eliminating p53; and E7 acts downstream of p53 bypassing the inhibition of Rb phosphorylation.
Specific aim 3 will examine the expression and activity of the G1 cyclins, D1-3 and E, cyclin dependent kinases (cdks), cdk2 and cdk4, and kinase inhibitory proteins (kips), p27 and p21, that are involved in the phosphorylation of Rb to determine how p53 inhibits phosphorylation and how E7 bypasses the p53 signals.
Specific aim 4 will use differential display of RNAs, from pairs of DNA damaged keratinocytes with and without E6 or E7, as a complementary approach to identify steps in the p53-mediated G1 arrest of DNA damaged keratinocytes. Taken together these approaches will provide important insights into interactions of the HPV oncogenes with the p53 pathway.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA064795-01
Application #
2107479
Study Section
Special Emphasis Panel (SRC (86))
Project Start
1994-12-29
Project End
1999-11-30
Budget Start
1994-12-29
Budget End
1995-11-30
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Fu Xi, Long; Schiffman, Mark; Ke, Yang et al. (2017) Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18. Int J Cancer 140:1747-1756
Wallace, Nicholas A; Khanal, Sujita; Robinson, Kristin L et al. (2017) High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway. J Virol 91:
Wallace, Nicholas A; Galloway, Denise A (2015) Novel Functions of the Human Papillomavirus E6 Oncoproteins. Annu Rev Virol 2:403-23
Wallace, Nicholas A; Robinson, Kristin; Howie, Heather L et al. (2015) ?-HPV 5 and 8 E6 disrupt homology dependent double strand break repair by attenuating BRCA1 and BRCA2 expression and foci formation. PLoS Pathog 11:e1004687
Galloway, Denise A; Laimins, Laimonis A (2015) Human papillomaviruses: shared and distinct pathways for pathogenesis. Curr Opin Virol 14:87-92
Wallace, Nicholas A; Galloway, Denise A (2014) Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses. Semin Cancer Biol 26:30-42
Wallace, Nicholas A; Robinson, Kristin; Galloway, Denise A (2014) Beta human papillomavirus E6 expression inhibits stabilization of p53 and increases tolerance of genomic instability. J Virol 88:6112-27
Xu, Mei; Katzenellenbogen, Rachel A; Grandori, Carla et al. (2013) An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes. Virology 446:17-24
Carter, Joseph J; Daugherty, Matthew D; Qi, Xiaojie et al. (2013) Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes. Proc Natl Acad Sci U S A 110:12744-9
Wallace, Nicholas A; Gasior, Stephen L; Faber, Zachary J et al. (2013) HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition. Virology 443:69-79

Showing the most recent 10 out of 39 publications